REFERENCES
- Sowjanya B, Sreenivasulu U, Naidu JN, . End stage renal disease, differential diagnosis, a rare genetic disorder: bardet-biedl syndrome: case report and review. Indian J Clin Biochem. 2011;26:214–216.
- Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2011;12:35.
- Kuo CC, Lee CT, Ho SC, . Hemodialysis and the risk of stroke: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Nephrology (Carlton). 2012;17:243–248.
- Fassett RG, Robertson IK, Mace R, . Palliative care in end-stage kidney disease. Nephrology (Carlton). 2011;16:4–12.
- Zheng K, Newman MW, Veinot TC, . Using online peer-mentoring to empower young adults with end-stage renal disease: a feasibility study. AMIA Annu Symp Proc. 2010;2010: 942–946.
- McDonald SP, Tong B. Morbidity burden of end-stage kidney disease in Australia: hospital separation rates among people receiving kidney replacement therapy. Nephrology (Carlton). 2011;16:758–766.
- Trabulus S, Guven GS, Altiparmak MR, . DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease. Mol Biol Rep. 2012;39:6995–7001.
- Prakash S, Prasad N, Sharma RK, . Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease. Cytokine. 2012;58:261–266.
- George GP, Mittal RD. Genetic polymorphisms in MHC-encoded antigen processing gene TAP2: a case-control study in end-stage renal disease patients of North India. Transpl Immunol. 2011;24:220–223.
- Borkar M, Tripathi G, Sharma RK, . Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease. Inflamm Res. 2011;60:399–407.
- Larsen T, Mose FH, Bech JN, . Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man. Clin Exp Hypertens. 2012;34:567–574.
- Schwartz IF, Grupper A, Soetendorp H, . Attenuated glomerular arginine transport prevents hyperfiltration and induces HIF-1alpha in the pregnant uremic rat. Am J Physiol Renal Physiol. 2012;303:F396–404.
- Tsai KD, Chang WW, Lin CC, . Differential effects of LY294002 and wortmannin on inducible nitric oxide synthase expression in glomerular mesangial cells. Int Immunopharmacol. 2012;12:471–480.
- Zhou TB, Qin YH, Su LN, . ACE I/D gene polymorphism can’t predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One. 2011;6:e19599.
- Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088–1101.
- Egger M, Davey SG, Schneider M, . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
- de Prado A, Donate T, Martinez E, . Endothelial nitric oxide synthase gene polymorphism in dialysis patients. Adv Perit Dial. 2002;18:18–20.
- Nagase S, Suzuki H, Wang Y, . Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem. 2003;244:113–118.
- Thaha M, Pranawa, Yogiantoro M, . Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin Nephrol. 2008;70:144–154.
- Marson BP, Dickel S, Ishizawa MH, . Endothelial nitric oxide genotypes and haplotypes are not associated with end-stage renal disease. DNA Cell Biol. 2011;30:55–59.
- El-Din BS, Hamdy SM. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. Ren Fail. 2011;33:878–884.
- Noiri E, Satoh H, Taguchi J, . Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002;40:535–540.
- Casas JP, Bautista LE, Humphries SE, . Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109:1359–1365.
- Yu CK, Casas JP, Savvidou MD, . Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. BMC Pregnancy Childbirth. 2006;6:7.
- Su MT, Lin SH, Chen YC. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update. 2011;17:803–812.
- Shaik AP, Sultana A, Bammidi VK, . A meta-analysis of eNOS and ACE gene polymorphisms and risk of pre-eclampsia in women. J Obstet Gynaecol. 2011;31:603–607.